Mio Yamaguchi-Tanaka

8PUBLICATIONS
9CO-AUTHORS
Molecular targetsTumour immunologyRespiratory diseasesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 17, 2026
T-Cell Immunoglobulin and Mucin Domain 1 (Tim1) as a Prognostic Factor Associated With Therapeutic Resistance in Human Breast Carcinoma.

|Jan 21, 2026
Infiltration of TIM4-positive intratumoral macrophages serves as an adverse prognostic factor in breast cancer.

Mio Yamaguchi-Tanaka, Kiyoshi Takagi, Miyu Takahashi

|Jan 08, 2025
Discoidin Domain Receptor 2 Contributes to Breast Cancer Progression and Chemoresistance by Interacting with Collagen Type I.

Ai Sato, Kiyoshi Takagi, Momoka Yoshida

|Dec 17, 2024
Regulation of Stromal Cells by Sex Steroid Hormones in the Breast Cancer Microenvironment.

Mio Yamaguchi-Tanaka, Kiyoshi Takagi, Ai Sato

|Nov 09, 2024
Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance.

Shiori Fujisawa, Kiyoshi Takagi, Mio Yamaguchi-Tanaka

|May 13, 2023
Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker.

Ai Sato, Kiyoshi Takagi, Ayano Yoshimura

Pageof 2

Frequent Collaborators

5 joint publications

Yasuhiro Miki

5 joint publications

Minoru Miyashita

5 joint publications

Ai Sato

5 joint publications

Takashi Suzuki